
Management of COVID-19 on board the mixed cargo ship Aranui 5
Author(s) -
JeanClaude Chatard,
Jean-Marc Le Gac,
Sylvie Gonzalo,
P Vaysse,
Mathieu Coulange
Publication year - 2021
Publication title -
international maritime health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.266
H-Index - 17
eISSN - 2081-3252
pISSN - 1641-9251
DOI - 10.5603/imh.2021.0031
Subject(s) - crew , cruise , covid-19 , on board , pcr test , aeronautics , medicine , medical emergency , advertising , geography , business , engineering , polymerase chain reaction , archaeology , disease , biology , biochemistry , infectious disease (medical specialty) , gene , aerospace engineering
During cruises, the management of coronavirus disease 2019 (COVID-19) infections poses serious organizational problems such as those encountered in 2020 by the Zaandam, the aircraft carrier Charles de Gaulle or the Diamond Princess. In French Polynesia, the mixed cargo ship Aranui 5 transports both tourists and freight to the Marquesas Islands. The purpose of this article is to show how COVID-19 infections were diagnosed and contained before and after passengers boarded a cruise.